Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Developing HLA Typing Prep System for German Bone Marrow Donor Database

NEW YORK (GenomeWeb News) – Fluidigm today announced an agreement to develop and supply a custom version of its high-throughput library prep system to the DKMS, or the German Bone Marrow Donor Database, Life Science Lab.

Tübingen, Germany-based DKMS finds stem cell donors for patients with blood cancer and other blood diseases. HLA testing determines tissue compatibility between transplant recipients and donors, and the new system being developed, called Access Array System, would allow DKMS to characterize the HLA genes from thousands of samples a week for its donor registry, Fluidigm said.

The Access Array System will automate library preparation for next-generation sequencing with an integrated fluidic circuit to increase sample throughput. Fluidigm said the format "specifically addresses the sample throughput and quality requirements demanded by DKMS, while meeting the complexity of library prep for HLA typing."

DKMS anticipates having the new system running in the fall.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.